Radius Health (RDUS) Tops Q4 EPS by 48c, Revenues Beat; Offers FY20 Revenue Guidance Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Radius Health Announces Fourth Quarter and Full-Year 2019 Operating Results
February 27, 2020 7:30 AM ESTTYMLOS® U.S. net sales grew to $56 million in the fourth quarter of 2019,
 totaling $173M for full-year 2019, exceeding the Companys guidance of $168 to 172M
TYMLOS exited 2019 with majority share in new patients1, on track for market leadership in 2020
2020 TYMLOS U.S. net revenue expected to be between $220 and $235M and  full-year cash burn expected to be below $80M
Recruitment of three Phase 3 studies is advancing and expected to be completed in 2020, with anticipated data read-outs in... More
